The hydroxyethylene dipeptide isosteres L-682,679, L-684,414, L-685,434, and L-685,458 were synthesized in a few steps by a sequence involving an allyltrichlorostannane coupling with an α-amino aldehyde, followed by hydroboration of the corresponding 1,2-syn and 1,2-anti amino alcohols to give the diols, lactonization under TPAP conditions, lactone opening, and peptide coupling with the desired amine or dipeptide amide. The present synthetic approach represents a practical entry to a large range of other dipeptide isosteres.
Introduction
In the last several years there have been major research efforts towards the development of clinically useful inhibitors of aspartyl proteases. [1] [2] [3] [4] [5] [6] [7] This worldwide search has led to various peptide isosteres, wherein the scissile peptide bond is replaced by a hydrolytically more stable isosteric functional group. In this context, the hydroxy amino acid framework B (Figure 1) , where the peptide linkage of the sequence in structure A is replaced by a CH(OH)CH 2 group, constitutes a useful class of aspartyl protease inhibitors. 1-7
Figure 1 Core units of HIV protease inhibitors

HIV-1 Protease Inhibitors
The acquired immunodeficiency syndrome (AIDS) remains a serious public problem, especially in developing countries where it has now reached tragic dimensions and treatment is affordable only for a small percentage of infected people. The HIV virus, the causative agent of AIDS, is a highly mutable lentivirus, a member of the ret-rovirus family Retroviriadae, whose genome is encoded in RNA. Success in the development of HIV-Protease inhibitors as drugs was based upon early recognition of the central role of this enzyme in viral maturation and an intensive effort toward gaining an understanding of its structure and function. 1-7 L-685, 434 (1) is a potent HIV-1 protease inhibitor (IC 50 = 0.23 nM) containing (1S,2R)-1amino-2-hydroxyindan P 2 ′ ligand ( Figure 2 ). 8, 9 This inhibitor was found to block the spread of HIV-1 in T-lymphoid cells, being a highly potent and selective HIV protease inhibitor.
The pseudo pentapeptide L-682,679 (2) is a highly potent and selective inhibitor of HIV-1 protease (IC 50 = 0.42 nM, Figure 2 ). 10 Structural manipulations of various portions of this molecule provided compounds with enhanced potency, selectivity, and solubility.
g-Secretase Inhibitors
Alzheimer's disease (AD), a physical disease which attacks brain cells, nerves and transmitters, is the most common cause of dementia. [11] [12] [13] [14] [15] New drugs are being developed which seek to slow down the rate of mental decline, but they are promising only in the early stages of the disease. β-Secretase inhibitors are already under development and inhibition of amyloid β-peptide (Aβ) production is the desired goal. Compounds that would inhibit either βor γ-secretase could potentially block Aβ production and be useful in treating Alzheimer's disease. [11] [12] [13] [14] [15] L-685,458 (3) is a potent inhibitor of γ-secretase (IC 50 = 17nM) and is of potential therapeutic benefit in the treatment of Alzheimer's disease and other neurological disorders ( Figure 2 ). [16] [17] [18] This compound, originally developed as an HIV protease inhibitor, was found to be a poor inhibitor of HIV protease, but a potent inhibitor of γsecretase. L-685,458 (3) is a novel inhibitor of AβPP-γsecretase activity, with a similar potency for inhibition of Aβ(42) and Aβ(40) peptides. Elevated levels of Aβ(42) peptide formation have been linked to early onset of familiar AD-causing gene mutations in the amyloid β-protein precursor (AβPP) and the presenilins. Sequential cleavage of AβPP by βand γ-secretase generates the Nand C-termini of the Aβ peptide, making both the βand γ-secretase enzymes potential therapeutic targets for AD. [16] [17] [18] L-685,458 (3) contains a hydroxyethylene dipeptide isostere that should serve as a transition state analogue mimic to direct the inhibitor to the active site of an aspartyl protease target ( Figure 2 ). L-684,414 (4) , the ketone derivative, was also found to be active (IC 50 = 181 nM) but less so than L-685,458 (3) , as expected if the hydroxyethylene dipeptide is serving as a transition state mimic. The observations that the inhibitory potency of L-685,458 (3) is sensitive to the configuration of the hydroxylic carbon atom and that the substrate analogue L-682,679 (2) is processed by γ-secretase (IC 50 >10000 nM) and binds to the enzyme much less tightly than L-685,458 (3) provide strong evidence that L-685,458 (3) is an active site directed transition state analogue inhibitor for an aspartyl protease. This supports the conclusion that γ-secretase is an aspartyl protease and agrees with previous studies showing that other aspartyl protease transition state analogues inhibit γ-secretase activity in cells. [11] [12] [13] [14] [15] [16] [17] [18] Based on our initial results on allyltrichlorostannane additions to N-Boc-α-amino aldehydes and attracted by the highly potent inhibition of AβPP γ-secretase activity of L-685,458 (3), as well as by the HIV inhibitory potency of 1, 2 and 4, we initiated a project directed towards their total synthesis. An efficient and flexible synthesis is essential to provide material for more extensive biological studies, along with access to novel analogues. The approach described here to L685,434 (1), L-682,679 (2), L-685,458 (3) , and L-684,414 (4) might also give access to additional derivatives with potential relevance for biological evaluation.
Results and Discussion
Allylsilane Additions to N-Boc-a-amino Aldehydes
We began this work a few years ago, and observed that allylsilanes react with N-Boc-α-amino aldehydes in the presence of SnCl 4 to give 1,2-syn N-Boc-α-amino alcohols that are key intermediates (molecules of type C, Figure 1 ) for the preparation of hydroxyethylene dipeptide isosteres. [19] [20] [21] [22] [23] [24] [25] We have also reported the first successful examples of allylsilane additions to chiral dipeptide aldehydes. 24 This synthetic methodology allows compounds with programmed variations of substituents to be synthesized and is particularly important in the screening of the pharmacological activity and in the study of structure-activity relationships directed toward the design of the best substituents for positions 1 and 4 in structure C (R 1 and R groups, Figure 1 ).
In order to prepare these allylsilanes, the cerium reagent generated from cerium(III) chloride and trimethylsilylmethylmagnesium chloride was reacted with methyl ester 5 to give an intermediate bis(trimethylsilylmethyl)carbinol which, after treatment with amberlyst 15 ® in n-hexane, gave allylsilane 6 in 97% yield for the two-step sequence (Scheme 1). 26, 27 Treatment of methyl ester 7 under the same conditions gave an intermediate carbinol that was treated with silica gel in hexane to give allylsilane 8 in 93% yield for the two-step sequence. 19 Scheme 1 Preparation of allylsilanes 6 and 8
The next step involved a spectroscopic study ( 1 H, 13 C, and 119 Sn NMR) of the reactions of allylsilanes 6, 8 and 9 with SnCl 4 (Scheme 2). Allylsilanes 6, 8 and 9 and SnCl 4 (0.5 M solution in CDCl 3 ) were mixed in order to promote ligand exchange, leading to the corresponding allyltrichlorostannanes. 22 For allyltrimethylsilane (9) (0.5 M in CDCl 3 ) the ligand exchange producing allyltrichlorostannane (10) and Me 3 SiCl is complete after 120 minutes at room temperature (Scheme 2). For allylsilane 6 (0.5 M in CDCl 3 ) the metathesis to give 11 and Me 3 SiCl is faster, as expected for a 1,1-disubstituted olefin, being complete after 60 minutes at room temperature. 22 Upon addition of SnCl 4 to a solution of chiral allylsilane 8 in CDCl 3 , at -60°C, as well as at 25°C, a slightly yellow homogeneous solution was obtained. The resulting NMR spectra at -60°C showed the formation of Me 3 SiCl and complete consumption of the allylsilane 8 within 1 minute to give allyltrichlorostannane 12. It appears that the oxygen functionality is responsible for the rapid ligand exchange reaction observed even at low temperatures for this particular allylsilane and SnCl 4 . The ligand exchange reaction is probably facilitated by coordination of tin to this oxygen followed by cleavage of the carbon-silicon bond by a free chloride ion. We have observed 119 Sn resonance signals at -27 ppm for allylstannanes 10 and 11. The tin chemical shift for allylstannane 12 appeared at -187 ppm. We believe that tin chemical shifts are highly sensitive to oxygen bonding, We next moved to investigate the allyltrichlorostannane additions to chiral aldehydes 13a-c. In order to confirm the facial selectivities of the (S)-N-Boc-α-amino aldehydes 13a-c, we reacted them with allyltrichlorostannane 10 (Scheme 3, Table 1 ). [19] [20] [21] [22] [23] [24] [25] 
Scheme 3 Allyltrichlorostannane addition to α-amino aldehydes 13a-c
In all cases, the major product results from a chelationcontrolled reaction that mainly gives the 1,2-syn-isomers 14a-c, showing that the (S)-α-amino aldehydes 13a-c have a preference for anti-Felkin addition (Si face at-tack). 28, 29 The increased steric bulk of the R group gives better diastereoselection. 1d,28-31 Under the same conditions, chiral allyltrichlorostannane 12 reacted with (S)-α-amino aldehydes 13a-c to give a mixture of 1,2-syn (16a-c) and 1,2-anti (17a-c) diastereomers with useful diastereoselectivities, favoring the 1,2syn-isomer with anti-Felkin addition and aldehyde Si face attack (Scheme 4). Results of reactions of 12 with (S)-aldehydes 13a-c are summarized in Table 2 . [19] [20] [21] [22] [23] [24] [25] Scheme 4 Chiral allyltrichlorostannane addition to α-amino aldehydes 13a-c As we know from previous work that the chiral allyltrichlorostannane 12 has a preference for Si face ap- 
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proach, this is an example of a matched reaction. 19 It should be noted that this reaction gives a very important subunit with a double bond and a benzyl protected primary alcohol that can be further manipulated. 32, 33 The 1,2-syn relative stereochemistry of the major products was unambiguously established by spectroscopic analysis of the corresponding trans-oxazolidines 18a-c (upon irradiation of the hydrogens adjacents to H a and H b ). Observed average coupling constants ( 3 J = 1.0 to 4.6 Hz) indicate that protons H a and H b are on opposite faces of the heterocyclic ring, and therefore, the oxazolidines are derived from 1,2-syn adducts (Scheme 5). 34
Scheme 5 Coupling constant analysis
The stereoselectivity of these reactions is consistent with a mechanism involving transmetalation of the allylsilanes to give an intermediate allyltin trichloride. 22, 35 We expect such reactions to be dominated by the stereogenic center next to the aldehyde function. We believe that the observed selectivity can be explained by an equilibrium between the intramolecular hydrogen bond conformer D and the non-bonded conformer E (Figure 3 ). 36 When the form D predominates (bulkier R groups), the syn-isomer is fa-vored, whereas the prevalence of the E-like conformer (smaller R groups) leads to the anti-isomer. The nucleophile selects the less hindered Si-face, forming a six membered transition state F where the chiral residue of the aldehyde occupies a pseudo-equatorial position. Our disconnection for the synthesis of compounds 2-4 is illustrated for inhibitor 3, summarized in Scheme 6. Not surprisingly, compound 3 is viewed as arising from 2 by either alcohol oxidation followed by selective 1,2-anti reduction 37 or by using the Mitsunobu inversion protocol. 38 Further analysis involved cleavage of the C-N peptide bond to give fragments 19 and 20. Carboxylic acid 19, the core unit common for the synthesis of compounds 1-4, is viewed as arising from α-amino aldehyde 13b by selective allyltrichlorostannane addition followed by hydroboration of the double bond and oxidation of the resulting primary alcohol. Dipeptide 20 may be dissected in a straightforward manner to give carboxylic acid 21 and amide 22.
Our approach to aspartyl protease inhibitors 1-4 began with N-Boc-phenylalaninal (13b), a useful synthetic intermediate, easily prepared from α-phenylalanine ethyl ester by Boc protection followed by DIBALH reduction. [28] [29] [30] [31] [32] [33] According to a previously established experimental procedure, allylsilane 6 and SnCl 4 (0.5 M solution in CH 2 Cl 2 ) were mixed before the addition of a solution of the aldehyde in order to promote in situ ligand exchange, leading to the corresponding allyltrichlorostannane 11 (Scheme 2). [19] [20] [21] [22] [23] [24] [25] Addition of the aldehyde 13b to a CH 2 Cl 2 solution of allyltrichlorostannane 11 at -78°C gave the 1,2-syn amino alcohol 23 in 94% yield for the two-step se- 13 C NMR spectroscopic analysis of the purified product mixture. The 1,4-syn and anti-products could not be separated and were characterized as mixtures. b Averages of at least three runs with ratios ±3%. c Combined yields of products isolated chromatographically (silica gel), after 2 steps (reduction to the aldehyde and coupling with allyltrichlorostannane). . [28] [29] [30] [31] [32] [33] The ratio was determined by 1 H and 13 C NMR spectroscopic analysis of the crude mixture, with averages of at least three runs with ±3% accuracy.
It is essential to promote the ligand exchange reaction before addition of the aldehyde in order to get good yields and selectivities. This reaction benefits from the fact that the real nucleophile is the allyltrichlorostannane and not the allylsilane itself. If the allyltrichlorostannane addition reaction is carried out from -78°C to room temperature, we have observed loss of the Boc protecting group with the corresponding deprotected homoallylic alcohol 24 being isolated in 82% yield and having essentially the same selectivity. dicated that hydrogens Ha and Hb are on opposite faces of the heterocyclic ring and, therefore, the oxazolidine is derived from 1,2-syn adduct (Scheme 7). 34, 39, 40 Alternatively, amino alcohol 24 was transformed to the corresponding oxazolidinone 26 (70%), followed by 1 H NMR coupling constant analysis. The observed coupling constant (J Ha/Hb = 5.1 Hz) indicates that hydrogens Ha and Hb are on opposite faces of the heterocyclic ring (Scheme 7).
The double bond in acetonide 25 was oxidatively hydroborated at 0°C with BH 3 ⋅SMe 2 to give primary alcohols 27 and 28 in 93% overall yield (Scheme 8). 6, [39] [40] [41] The use of the more hindered 9-BBN gave essentially the same result, although in lower yields (65%). Although these two isomers are not easily separated, we were able to get pure isolated compounds after careful silica gel flash column chromatography. A coupling constant of 4.0 Hz between H a and H b is again observed for alcohols 27 and 28. 6, [39] [40] [41] The relative stereochemistry for undesired primary alcohol 28 was ascertained by conversion to the piperidine derivative 29 after a two-step sequence involving reaction with Ph 3 P, I 2 and imidazole, and treatment of the intermediate iodide with 4 M HCl in MeOH followed by K 2 CO 3 in DMF (Scheme 9). The illustrated NOESY interactions confirmed the proposed relative stereochemistry for cyclic amino alcohol 29.
Selective acetonide deprotection in alcohols 27 and 28 was achieved by using the complex BF 3 ⋅2AcOH at room temperature to give diols 30 and 31 (not separated by sil-ica gel column chromatography) in 94% overall yield (Scheme 8). A better approach to these diols involved direct hydroboration of the unprotected homoallylic alcohol 23 with BH 3 ⋅SMe 2 in THF at 0°C to give a mixture of diols 30 and 31 in 93% yield (Scheme 10). These diols were not separated but were converted directly to a mixture of lactones 32 and 33 (95% yield) by treatment with tetrapropylammonium perruthenate (TPAP) and N-methylmorpholino N-oxide (NMO) in the presence of molecular sieves at room temperature. 42,43 These lactones were readily separated by flash column chromatography. Although these lactones have been prepared earlier by others, the relative stereochemistry for cis-lactone 33 was ascertained by NOESY experiments (observed interaction between H a and H b ). Attempts to obtain more of the desired trans-lactone 32 by a deprotonation and reprotonation sequence of cis-lactone 33 led to a 70:30 mixture of lactones 32:33 in 96% yield (Scheme 10). It is interesting to point out that cis-lactone 33 is also an important intermediate for the synthesis of other potent HIV-1 protease inhibitors. 43b
Basic hydrolysis of desired trans-lactone 32 (LiOH, 1,2dimethoxyethane), silylation (TBSCl, imidazole, DMF, r.t., 12h) of the resulting carboxylate, and selective desilylation of the acylsiloxy moiety (MeOH) cleanly provided 19 in excellent yield after purification by silica gel flash chromatography (Scheme 11). ates aiming at the synthesis of hydroxyethylene isosteres and is prepared in 4 steps and 24% overall yield from 23, being amenable to a gram scale-up.
The carboxylic acid 19 is a versatile intermediate for the introduction of different functional groups in intermedi-
Compound L-685,434 (1) is readily prepared from carboxylic acid 19 by a simple peptide coupling reaction with (1S,2R)-1-amino-2-hydroxyindane (34) followed by TBS removal with TBAF in 70% yield for the two-step sequence (Scheme 11). [6] [7] [8] Compounds 2-4 are also prepared from the same carboxylic acid precursor 19. In order to prepare inhibitors 2 and 3 we first obtained the dipeptide amide NH 2 Leu-PheNH 2 (35) (Scheme 12). Peptide type coupling of N-Boc-phenylalanine (36) with a 25% solution of ammonium hydroxide followed by Boc deprotection with MeOH/AcCl gave amide 22 in 71% overall yield.
Peptide coupling between carboxylic acid 21 and amide 22, followed by Boc deprotection, gave NH 2 Leu-PheNH 2 35 in 85% overall yield (Scheme 13).
Compound L-682,679 (2) is readily prepared from carboxylic acid 19 and dipeptidic amine 35 by a simple peptide coupling reaction followed by TBS deprotection with TBAF in 86% overall yield (Scheme 13). 10 Oxidation of the hydroxyl function in 2 with pyridinium dichromate (PDC) in DMF gave inhibitor L-684,414 (4) in 85% isolated yield. Selective reduction of L-684,414 (4) with LiBH 4 gave γ-secretase inhibitor L-685,458 (3) in 93% yield and 95:5 diastereoselection (Scheme 13). 37 Another approach to the synthesis of L-685-458 (3) is by using the corresponding 1,2-anti amino alcohol 39 prepared from 23. Of the available options to promote the inversion of the hydroxyl stereochemistry of 23 in order to . 38 The p-nitrobenzoate ester 37 was isolated in 60% yield together with about 10% of elimination product 38 and 20% of recovered starting material.
Hydrolysis of the 4-nitrobenzoate 37 with lithium hydroxide gave the desired 1,2-anti amino alcohol 39 in 98% yield (Scheme 14). Another approach for the preparation of 39 involved Dess-Martin 44 oxidation of 23 at 0°C to give ketone 40 (77% yield) followed by LiBH 4 37 reduction in THF at -60°C (Scheme 14). Although we were able to isolate the amino alcohol 39 in good yields and with 94:6 diastereoselectivity, this protocol is sometimes hard to reproduce since a lot of care must be taken in order to avoid rearrangement to the conjugated ketone 40.
The 1,2-anti relative stereochemistry for 39 was tentatively assigned by spectroscopic analysis of the cis-oxazolidine 41 (J Ha-Hb = 4.7 Hz), (Scheme 14). [23] [24] [25] 34 As the observed coupling constants for oxazolidines 25 (4.0 Hz) and 41 (4.7 Hz) were very close, we decided to check the differences in chemical shifts in compounds 23 and 39. The relative stereochemistry for compounds 23 and 39 was confirmed using Heathcock's model for β-hydroxy carbonyl compounds (Scheme 15 and Table 3 ). 45 Considering an intramolecular hydrogen bond in CDCl 3 solution between NH and OH in both compounds, and after analysis of 1 H and 13 C NMR chemical shifts we observed that:
-C 1 and C 4 in 23 are more deshielded than C 1 ′ and C 4 ′ in 39;
-C 2 and C 3 in 23 are more shielded than C 2 ′ and C 3 ′ in 39; and -Ha and Hb in 23 are more shielded than Hc and Hd in 39.
It is also interesting to observe the difference in the melting points of compounds 23 and 39 (Scheme 15). The 1,2syn amino alcohol 23, where an intramolecular hydrogen bond between NH and OH is expected, leading to a trans relationship between the two substituents, has a melting point of 95.5-97.8°C. The 1,2-anti amino alcohol 39, where an intramolecular hydrogen bond in the solid state is not expected to be favored over intermolecular interaction, has a higher melting point (mp 141.5-142.3°C). These results are consistent with the proposed stereochemistry for 23 and 39.
The next step involved a direct hydroboration of 1,2-anti homoallylic alcohol 39 with BH 3 ⋅SMe 2 to give a 55:45 mixture of diols 42 and 43 in 93% overall yield 
Conclusions
This convergent asymmetric approach to aspartyl protease inhibitors L-685,434 (1), L-682,679 (2), L-685,458 
Homoallylic Alcohols 14a-c; General Procedure
To a solution of allylsilane 9 (1.5 mmol) in CH 2 Cl 2 (5 mL) at r.t. was added SnCl 4 (1.4 mmol). The resulting solution was stirred at r.t. for 2 h and then cooled to -78°C when a solution of aldehyde 13a-c (1.4 mmol) in CH 2 Cl 2 (2 mL) was added. This mixture was stirred for 2 h at -78°C and quenched by the slow addition of a sat. aq solution of NaHCO 3 (5 mL) followed by CH 2 Cl 2 (5 mL). The layers were separated and the aqueous layer was extracted with CH 2 Cl 2 (2 × 5 mL). The combined organic layers were dried (MgSO 4 ), filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (30% EtOAc-hexane) gave the corresponding homoallylic alcohols 14a-c. 
tert-Butyl (1S,2S)-2-Hydroxy
Homoallylic Alcohols 16a-c; General Procedure
To a solution of allylsilane 8 (1.5 mmol) in CH 2 Cl 2 (5 mL) at 0°C was added SnCl 4 (1.5 mmol). The resulting solution was stirred at 0°C for 5 min and then cooled to -78°C when a solution of aldehyde 13a-c (1.5 mmol) in CH 2 Cl 2 (2 mL) was added. This mixture was stirred for 2 h at -78°C and quenched by the slow addition of a sat. aq solution of NaHCO 3 (5 mL) followed by CH 2 Cl 2 (10 mL). The layers were separated and the aqueous layer was extracted with Butyl (1S,2S)-4-[(1S)-2-Benzyloxy-1-methylethyl Anal. Calcd for C 23 
tert-Butyl (1S,2S)-1-Benzyl-4-[(1S)-2-benzyloxy-1-methylethyl]-2-hydroxypent-4-enylcarbamate (16b)
tert-
Acetonides 18a-c; General Procedure
To a stirred solution of the corresponding amino alcohols 16a, 14b, 16c (1.4 mmol) in 2,2-dimethoxypropane (2 mL) at r.t. was added p-toluenesulfonic acid (2 mg), and the mixture was stirred for 46 h at r.t. Et 2 O (2 mL) was added, and the organic layer was washed with 10% NaHCO 3 (1 mL) and brine (1 mL). The organic layer was dried (MgSO 4 ), filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (10% EtOAc-hexane) afforded products 18a-c. 
tert-Butyl (4R,5R)-5-{2-[(1R)-2-Benzyloxy-1-methylethyl]allyl}-2,2,4-trimethyl-1,3-oxazolane-3-carboxylate (18a)
tert-Butyl (4S,5S)-5-Allyl-4-benzyl-2,2-dimethyl-1,3-oxazolidine-3-carboxylate (18b)
tert-Butyl (4R,5R)-5-{2-[(1R)-2-Benzyloxy-1-methylethyl]allyl}-4-isopropyl-2,2-dimethyl-1,3-oxazolane-3-carboxylate (18c)
(4S,5S)-2-Benzyl-5-[(tert-butoxycarbonyl)amino]-6-phenylhex-1-en-4-ol (23)
To a solution of allylsilane 6 (2.86 g, 14 mmol) in CH 2 Cl 2 (50 mL) at 0°C was added SnCl 4 (1.7 mL, 14 mmol). The resulting solution was stirred at 0°C for 2 h and then cooled to -78°C when a solution of aldehyde 13b (2.7 g, 11 mmol) in CH 2 Cl 2 (20 mL) was added. This mixture was stirred for 2 h at -78°C and quenched by the slow addition of a sat. aq solution of NaHCO 3 (50 mL) followed by CH 2 Cl 2 (100 mL). The layers were separated and the aqueous layer was extracted with CH 2 Cl 2 (2 × 25 mL). The combined organic layers were dried (MgSO 4 ), filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (30% EtOAc-hexane) gave the corresponding homoallylic alcohol 23 as a white solid. 
(2S,3S)-2-Amino-5-benzyl-1-phenylhex-5-en-3-ol (24)
After stirring at -78°C for 2 h, the above reaction was allowed to warm to r.t. before it was quenched by the addition of an aq sat. solution of NH 4 Cl. This procedure led to the isolation of amino alcohol 24 in 82% yield from α-amino aldehyde 13b. 
(4S,5S)-4-Benzyl-5-(2-benzylprop-3-enyl)-3-(tert-butoxycarbonyl)-2,2-dimethyl-1,3-oxazolidine (25)
To a stirred solution of the amino alcohol 23 (0.53 g, 1.4 mmol) in 2,2-dimethoxypropane (20 mL) at r.t. was added p-toluenesulfonic acid (13 mg), and the mixture was stirred for 46 h at r.t. Et 2 O (20 mL) was added and the organic layer was washed with 10% aq NaHCO 3 (10 mL) and brine (10 mL 
(4S,5S)-4-Benzyl-5-(2-benzylprop-2-enyl)-1,3-oxazolidin-2-one (26)
To a solution of amino alcohol 24 (60 mg, 0.213 mmol) in CH 2 Cl 2 (1.2 mL) at 0°C was added slowly a solution of triphosgene (76 mg, 0.256 mmol) in CH 2 Cl 2 (1.2 mL). The mixture was stirred for 3 h at r.t., diluted with CH 2 Cl 2 (10 mL), and washed with aq sat. NaHCO 3 (5 mL). The aqueous phase was extracted with CH 2 Cl 2 (2 × 10 mL) and the organic layer dried (MgSO 4 ) and concentrated to provide the crude product, which was purified by flash chromatography (20% EtOAc-hexane). 
Hydroboration of Acetonide 25
To a solution of acetonide 25 (0.59 g, 1.4 mmol) in THF (10 mL) cooled to 0°C was added the BH 3 ⋅SMe 2 complex (0.9 mL of a 2 M solution in THF, 1.8 mmol). This mixture was stirred at 0°C until complete consumption of starting material, as determined by TLC (ca. 24 h). EtOH (2 mL) was added followed by an aq 3 M solution of NaOH (6 mL) and 30% H 2 O 2 (6 mL). The mixture was stirred 10 h at r.t. EtOAc (10 mL) was added, and the organic layer was separated and washed with aq 10% Na 2 SO 3 (10 mL) and brine (10 mL). The combined organic layer was dried (MgSO 4 ), filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (30% Et 2 O-hexane) produced the desired product (2′R,4S,5S)-27 (0.34 g, 55%) and its isomer (2′S,4S,5S)-28 (0.23 g, 38%) as colorless oils. 
(4S,5S)-4-Benzyl-5-[(2R)-2-benzyl-3-hydroxypropyl]-3-(tertbutoxycarbonyl)-2,2-dimethyl-1,3-oxazolidine (27)
(4S,5S)-4-Benzyl-5-[(2S)-2-benzyl-3-hydroxypropyl]-3-(tert-butoxycarbonyl)-2,2-dimethyl-1,3-oxazolidine (28)
(2S,3S,5S)-2,5-Dibenzylpiperidin-3-ol (29)
To a solution of imidazole (34.4 mg, 0.51 mmol) and Ph 3 P (48.6 mg, 0.185 mmol) in CH 2 Cl 2 (2 mL) at 0°C was added I 2 (47 mg, 0.19 mmol). This mixture was stirred at 0°C for 15 min and then a solution of the alcohol (2′S,4S,5S)-28 (74 mg, 0.17 mmol) in CH 2 Cl 2 (1 mL) was added. The resulting mixture was stirred at 0°C for 15 min and then at r.t. for 12 h. The mixture was diluted with a sat. aq solution of Na 2 S 2 O 3 (1 mL) followed by addition of H 2 O (5 mL). The aqueous phase was extracted with CH 2 Cl 2 (3 × 10 mL), the combined organic layers were dried (MgSO 4 ) and concentrated to provide the crude product, which was purified by flash chromatography (5% EtOAc-hexane) to give 63 mg (68%) of the intermediate iodide. To a solution of this iodide (63 mg, 0.115 mmol) in a 50:50 mixture of EtOAc-DMF (2 mL) was added aq 4 M HCl (1.8 mL). This mixture was stirred at r.t. for 3 h, quenched by the addition of K 2 CO 3 (0.5 g) and H 2 O (5 mL) and allowed to stir at r.t. for 2 h. The volatiles were removed under reduced pressure and the remaining solvent was removed in vacuo (2 Torr). The product was purified by flash cromatography (5% MeOH-CH 2 Cl 2 ). 13 
Lactones 32 and 33
To a solution of amino alcohol 23 (2.25 g, 5.90 mmol) in THF (70 mL) cooled to 0°C was added the BH 3 ⋅SMe 2 complex (15.8 mL of a 2 M solution in THF, 29.5 mmol). This mixture was stirred at 0°C until complete consumption of starting material, as determined by TLC ( ca.24 h). EtOH (36 mL) was added followed by an aq 3 M solution of NaOH (74 mL) plus 30% H 2 O 2 (56 mL). The mixture was stirred at r.t. for 10 h. EtOAc (20 mL) was added and the organic layer was separated and washed with aq 10% Na 2 SO 3 (20 mL) and brine (20 mL). The combined organic layers were dried (MgSO 4 ), filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (50% EtOAc-hexane) gave a mixture of diols 30 and 31 (2.19 g, 93% yield) as a colorless oil. Solid TPAP (192 mg, 0.59 mmol) was added in one portion to a stirred mixture of diols 30 and 31 (2.18 g, 5.60 mmol), then a mixture of NMO (1.92 g, 16.5 mmol) and activated powdered molecular sieves (2.74 g) in CH 2 Cl 2 (6 mL) was added at r.t. under argon. On completion of the reaction, the mixture was filtered through a pad of silica gel, eluting with 7% EtOAc-hexane. The filtrate was evaporated and the residue was purified by column chromatography on silica gel using 7% EtOAc-hexane to give lactones 32 and 33, respectively, in 95% overall yield.
(3R,5S)-3-Benzyl-5-{(1S)-1-[(tert-butoxycarbonyl)amino]-2-phenylethyl}dihydrofuran-2-(3H)-one (32)
Yield: 1.15 g (53%); R f 0.60 (30% EtOAc-hexane). 
(2R,4S,5S)-2-Benzyl-5-[(tert-butoxycarbonyl)amino]-4-hydroxy-N-[(1S,2R)-2-hydroxy-1-indanyl]-6-phenylhexanamide (1)
A solution of 32 (982 mg, 2.4 mmol) in 1,4-dioxane (14 mL) was treated with a solution of LiOH in H 2 O (1 M, 2.6 mL, 2.6 mmol) and stirred at r.t. for 3 h. The reaction mixture was carefully acidified to pH 4 with citric acid and then extracted with EtOAc. The organic extracts were combined and washed with brine, dried (MgSO 4 ), filtered and evaporated in vacuo. The crude hydroxy acid was dissolved in DMF (30 mL), treated with tert-butyldimethylsilyl chloride (3.63 g, 24 mmol) and imidazole (1.95 g, 28.6 mol), and stirred for 24 h. MeOH (20 mL) was added to the mixture and it was stirred for 3 h, evaporated in vacuo, and then partitioned between 10% aq citric acid (50 mL) and EtOAc (200 mL). The organic layer was washed with brine, dried (MgSO 4 ), filtered and evaporated in vacuo. Purification by flash column chromatography (3% MeOH-CH 2 Cl 2 ) gave 19 (1.19 g, 94%) as a white foam. A solution of 19 (100 mg, 0.188 mmol), (1S,2R)-1-amino-2-hydroxyindan (34; 34.7 mg, 0.23 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (51 mg, 0.27 mmol) and 1-hydroxybenzotriazole (31 mg, 0.26 mmol) in DMF (5 mL) was stirred at r.t. for 15 h. The reaction mixture was diluted with EtOAc (25 mL) and the organic phase was washed with aq citric acid (pH 4), aq NaHCO 3 , and brine, dried (MgSO 4 ), filtered, and evaporated in vacuo. Purification by flash column chromatography (20% EtOAc-hexane) gave the corresponding silylated product.
Yield: 100 mg (80%); R f 0.32 (30% EtOAc-hexane). 
Silylated Product
(1R)-3-Benzyl-1-{(1S)-1-[(tert-Butoxycarbonyl)amino]-2-phe-nylethyl}but-3-enyl 4-Nitrobenzoate (37)
Method A: To a stirred solution of alcohol 23 (1.14 g, 3 mmol), Ph 3 P (6.2 g, 24 mmol) and p-nitrobenzoic acid (3.9 g, 24 mmol) in THF (50 mL) at r.t. was added di-tert-butyl azodicarboxylate (5.4 g) in THF (10 mL). The solution was then stirred at r.t. for 18 h, whereupon the volatile components were removed in vacuo and the residue purified by flash chromatography on silica gel (15% EtOAchexane) to give 37 as a white crystalline solid and 38 as a colorless oil.
Yield: 955 mg (60%); R f 0.47 (30% EtOAc-hexane); mp 137. 
tert-Butyl (1S)-2-Amino-1-benzyl-2-oxoethylcarbamate
A solution of N-Boc-Phe 36 (1.35 g, 5.1 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.06 g, 5.61 mmol) and 1-hydroxybenzotriazole (669 mg, 5.61 mmol) in a mixture of DMF (10 mL) and CH 2 Cl 2 (20 mL) was stirred at r.t. for 1 h. To the resulting suspension was aq (0.78 mL, 10.2 mmol) at 0°C and the mixture was stirred for 2 h at 0°C and 18 h at r.t. The mixture was diluted with EtOAc (25 mL) and the organic phase was washed with aq citric acid (pH 4), aq NaHCO 3 (2 × 10 mL) and brine (10 mL), dried (MgSO 4 ), filtered, and evaporated in vacuo. To a solution of this product in EtOAc-MeOH (50:50, 6 mL) at 0°C was added AcCl (2 mL). The resulting mixture was stirred for 30 min at 0°C and the solvent was removed in vacuo (2 Torr, 45°C) to give PheNH 2 . Purification by flash column chromatography (40% EtOAc-hexane) gave product 22 (0.594 g, 71% overall yield).
Boc-Protected 22
(2S)-N-[(1S)-2-Amino-1-benzyl-2-oxoethyl]-2-[(tert-butoxycarbonyl)amino]-4-methylpentanamide (Boc-Leu-Phe-NH 2 )
A solution of N-Boc-Leu 21 (0.948 g, 4. 
(1S,4R){(1)-Benzyl-4-[1-(1S)-carbamoyl-2-phenylethylcarbamoyl)-(1S)-3-methylbutylcarbamoyl]-2-oxo-5-phenylpentyl}carbamic Acid tert-Butyl Ester (4)
To a stirred solution of alcohol 2 (40 mg, 0.06 mmol) in DMF (1.5 mL) was added PDC (112 mg, 0.3 mmol) in one portion. The resulting reaction mixture was allowed to stirr at r. 
(3R,5R)-3-Benzyl-5-{(1S)-1-[(tert-butoxycarbonyl)amino]-2-phenylethyl}dihydrofuran-2-(3H)-one (44)
To a solution of amino alcohol 39 (0.560 g, 1.47 mmol) in THF (20 mL) cooled to 0°C was added BH 3 ⋅SMe 2 complex (4 mL of a 2 M solution in THF, 8 mmol). This mixture was stirred at 0°C until complete consumption of starting material, as determined by TLC (ca. 24 h). EtOH (19 mL) was added followed by a 3 M solution of NaOH (20 mL) and 30% H 2 O 2 (15 mL). The mixture was stirred at r.t. for 10 h. EtOAc (50 mL) was added and the organic layer was separated and washed with aq 10% Na 2 SO 3 (50 mL) and brine (5 mL). The combined organic layers were dried (MgSO 4 ), filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (50% EtOAc-hexane) gave a mixture of diols 42 and 43 (545 mg, 93%) as a colorless oil. Solid TPAP (46.5 mg, 0.14 mmol) was added in one portion to a stirred mixture of the diols 42 and 43 (545 mg, 1.36 mmol), followed by a suspension of NMO (465 mg, 4.3 mmol) and activated powdered molecular sieves (665 mg) in CH 2 Cl 2 (15 mL) at r.t. under argon. On completion, the mixture was filtered through a pad of silica gel, eluting with hexane-EtOAc (93:07). The filtrate was evaporated and the residue was purified by column chromatography on silica gel using 7% EtOAc-hexane to give 308 mg and 227 mg of lactones 44 and 45, respectively, in 97% overall yield. 13 C NMR (CDCl 3 , 75 MHz): δ = 28. 2, 29.7, 31.4, 36.1, 45.5, 54.3, 78.9, 79.8, 126.6, 128.4, 128.5, 128.6, 129.3, 136.4, 138.2, 155 .0, 177.4.
(2R,4R,5S)-2-Benzyl-5-tert-butoxycarbonylamino-4-(tert-butyldimethylsilyloxy)-6-phenylhexanoic Acid (46)
A solution of 44 (0.21 g, 5.3 mmol) in 1,2-dimethoxyethane (36 mL) was treated with a solution of LiOH in H 2 O (1 M, 36 mL, 36 mmol) and stirred at r.t. for 6 h. The reaction mixture was carefully acidified to pH 4 with aq citric acid, and then extracted with EtOAc. The organic extracts were combined and washed with brine, dried (MgSO 4 ), filtered, and evaporated in vacuo. The crude hydroxy acid (0.216 g) was dissolved in DMF (30 mL), treated with tert-butyldimethylsilyl chloride (7.98 g, 52.8 mmol) and imidazole (4.26 g, 0.06 mol). The solution was stirred for 15 h. The mixture was diluted with MeOH (6 mL), stirred for 3 h, and then evaporated in vacuo. The mixture was partitioned between aq citric acid and EtOAc. The organic layer was washed with brine, dried (MgSO 4 ), filtered, and evaporated in vacuo. Purification by flash column chromatography (3% MeOH-CH 2 Cl 2 ) gave 46 (204 mg, 73%) as a white foam. 
(1S,2R,4R)-{1-Benzyl-4-[1-(1S)-carbamoyl-2-phenylethylcarbamoyl)-(1S)-3-methylbutylcarbamoyl]-2-hydroxy-5-phenyl-pentyl}carbamic Acid tert-Butyl Ester (3)
To a solution of Boc-Leu-Phe-NH 2 (91.3 mg, 0.24 mmol) in EtOAc-MeOH (50:50, 3 mL) at 0°C was added AcCl (1 mL). The resulting mixture was stirred for 30 min at 0°C and the solvent was removed in vacuo (2 Torr, 45°C) to give NH 2 -Leu-Phe-NH 2 (35) in quantitative yield. A solution of 46 (100 mg, 0.19 mmol), H 2 NLeu-Phe-NH 2 (35) (63 mg, 0.23 mmol), 1-(3-dimethylaminopropyl)-3ethylcarbodiimide hydrochloride (51 mg, 0.27 mmol) and 1-hydroxybenzotriazole (36 mg, 0.26 mmol) in DMF (5 mL) was stirred at r.t. for 15 h. The reaction mixture was diluted with EtOAc (10 mL), and the organic phase was washed with aq citric acid (pH 4), aq NaHCO 3 and brine, dried (MgSO 4 ), filtered, and evaporated in vacuo. Purification by flash column chromatography (5% MeOH-CH 2 Cl 2 ) gave the the corresponding silylated product.
Yield: 135 mg (91%); R f 0.5 (70% EtOAc-hexane). This material was dissolved in a solution of Bu 4 NF in THF (1 M, 1.25 mL) and the solution was stirred at r.t. for 12 h. The reaction mixture was diluted with citric acid in Et 2 O (pH 4) and the resulting precipitate was collected by filtration, and dried in vacuo to give L-685,458 (3) . Further purification by flash column chromatography (6% MeOH-CH 2 Cl 2 ) gave L-685,458 (3) 
Silylated Product
Compound 3 From Ketone 4
LiBH 4 (127 mg, 0.50 mmol) was dissolved in EtOH (4 mL) at -5°C under N 2 , and then a solution of ketone 4 (0.25 mmol) in EtOH (3 mL) was added dropwise. After 24 h, the solution was quenched with H 2 O (2 mL) and extracted with EtOAc (2 × 10 mL). The combined organic extracts were washed with H 2 O (10 mL) and brine (20 mL), dried (MgSO 4 ), and concentrated under vacuum. The residue was purified by flash column chromatography (6% MeOH-CH 2 Cl 2 ) to give L-685,458 (3) as a white solid.
Yield: 93%. 18, 46, 47 
